Representing Clinical Study Schedule of Activities as FHIR Resources: Required Characteristic Attributes

Author:

Richardson Andy

Abstract

Introduction: The HL7 FHIR interoperability standard is nowimplemented widely to expose healthcare records, and the FHIR definitionalresources are being investigated and developed to enable research studyprotocol requirements to directly support research data collection from the clinicinto sponsors databases. Objective.  Methods:  A minimal setof attributes to model SoA scheduling requirements was identified, tested anddeveloped using graph methods. The model was tested using various standard, complex,and publicly available SoA examples. The ability of these examples to be generatedas FHIR resources compliant with the recently published HL7 Vulcan SoA ProjectImplementation Guide was tested.  Results: A minimum viable set of SoA characteristics hasbeen identified that can generate SoA FHIR Implementation Guide (IG) compliant resourcesconsistent with the scheduling and timing requirements of a study. Conclusion:  A minimumviable set of SoA characteristics able to describe common study timingrequirements for defining, creating, and confirming study specific FHIRresources was developed.  Although this workwas focused on creating SoAs in FHIR format, the same attributes should be presentand identifiable in SoA models in other formats. The findings here thereforemay have a broader applicability for confirming machine-readable SoArequirements.

Publisher

Society for Clinical Management

Reference27 articles.

1. 1. TransCelerate. Clinical Content & Reuse Solutions. Accessed August 3, 2023. https://www.transceleratebiopharmainc.com/assets/clinical-content-reuse-solutions/

2. 2. Common CSR Template: A Consistent Approach to Writing Compliant CSRs With Ease. Transcelerate Biopharma, Clinical Content & Reuse Solutions, www.transceleratebiopharmainc.com, 2004.

3. Accelerating the adoption of eSource in clinical research: a Transcelerate point of view;Parab AAMehta PVattikola A;Ther Innov Regul Sci,2020

4. Electronic health records: new opportunities for clinical research;Coorevits PSundgren MKlein GO;J Intern Med,2013

5. 5. US Food and Drug Administration. Real-world data: assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products. Published September, 2021. Accessed August 3, 2023. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/real-world-data-assessing-electronic-health-records-and-medical-claims-data-support-regulatory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3